Xuebijing Protects Against Septic Acute Liver Injury Based on Regulation of GSK-3β Pathway

• প্রধান লেখক: Liping Cao (লেখক), Zhenghong Li (লেখক), Yi Ren (লেখক), Mengmeng Wang (লেখক), Zhizhou Yang (লেখক), Wei Zhang (লেখক), Xiaoqin Han (লেখক), Mengya Yao (লেখক), Zhaorui Sun (লেখক), Shinan Nie (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: Frontiers Media S.A., 2021-04-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Xuebijing (XBJ), the only drug approved for the sepsis and multiple organ dysfunction, and its protective effects against acute liver injury (ALI) and its mechanism. The aim of this study was to evaluate the protective effect of XBJ on cecal ligation and perforation (CLP)-induced mouse ALI model and...